Navegação por autor "Lowndes, Catherine M."
Itens para a visualização no momento 1-6 of 6
-
Co-infection with malaria and HIV in injecting drug users in Brazil: a new challenge to public health?
Bastos, Francisco Inácio Pinkusfeld Monteiro et al. | Data do documento: 1999 -
Diagnostic detection of human immunodeficiency virus type 1 antibodies in urine: a Brazilian study
Oelemann, Walter Martin Roland et al. | Data do documento: 2002We evaluated, for the first time in Latin America, the performance of a commercial enzyme immunoassay (EIA) (Calypte Biomedical Corporation, Berkeley, Calif.) that detects human immunodeficiency virus type 1 (HIV-1)-specific ... -
Differential trends in mortality from AIDS in men and women in Brazil (1984-1995)
Lowndes, Catherine M. et al. | Data do documento: 2000Objective: To analyse trends in AIDS mortality in men and women in Brazil, for the period 1984±1995. Design and methods: National statistics on yearly numbers of reported deaths by cause, in conjunction with census population ... -
Perception of vulnerability to HIV infection in a cohort of homosexual/bisexual men in Rio de Janeiro, Brazil
Souza, Claudia Teresa Vieira de et al. | Data do documento: 1999 -
Sexual behaviour and infection rates for HIV, blood-borne and sexually transmitted infections among patients attending drug treatment centres in Rio de Janeiro, Brazil
Bastos, Francisco Inácio Pinkusfeld Monteiro et al. | Data do documento: 2000A survey was carried out in 2 drug use treatment centres (TCs) in Rio de Janeiro, Brazil, to assess risk behaviours, HIV infection and other sexually transmitted infections/blood-borne infections (STIs/BBIs). Two hundred ... -
Willingness to participate in HIV vaccine trials among a sample of men who have sex with men, with and without a history of commercial sex, Rio de Janeiro, Brazil
Souza, Claudia Teresa Vieira de et al. | Data do documento: 2003The study objective was to assess willingness of men who have sex with men (MSM) enrollled in a vaccine preparedness study ('Projeto Rio') to participate in phase III anti-HIV/AIDS vaccine trials. Overall, 57% of Projeto ...